{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:34:03Z","timestamp":1789450443566,"version":"build-2803163510"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003065","name":"Universit\u00e4t Wien","doi-asserted-by":"publisher","award":["EQU201903007793"],"award-info":[{"award-number":["EQU201903007793"]}],"id":[{"id":"10.13039\/501100003065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003065","name":"Universit\u00e4t Wien","doi-asserted-by":"publisher","award":["EQU20193007831"],"award-info":[{"award-number":["EQU20193007831"]}],"id":[{"id":"10.13039\/501100003065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["EQ U201903007793\\u2013EQU20193007831"],"award-info":[{"award-number":["EQ U201903007793\\u2013EQU20193007831"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"JDRF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["945268"],"award-info":[{"award-number":["945268"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115797"],"award-info":[{"award-number":["115797"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","award":["ANR-19-CE15-0014-01"],"award-info":[{"award-number":["ANR-19-CE15-0014-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","award":["ANR-10-LABX-0073"],"award-info":[{"award-number":["ANR-10-LABX-0073"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011570","name":"Diabetes Research Netherlands Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011570","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003092","name":"Diabetes Fonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007028","name":"Leona M. and Harry B. Helmsley Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008664","name":"Juvenile Diabetes Research Foundation United Kingdom","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ebiom.2023.104740","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T12:39:14Z","timestamp":1690893554000},"page":"104740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Tryptophan metabolism promotes immune evasion in human pancreatic \u03b2 cells"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1089-2837","authenticated-orcid":false,"given":"Latif","family":"Rachdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9137-7951","authenticated-orcid":false,"given":"Zhicheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Berthault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Louren\u00e7o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Fouque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Domet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Armanet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvaine","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Peakman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Mallone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Scharfmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2023.104740_bib1","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.4049\/jimmunol.1401572","article-title":"The programmed death-1 immune suppressive pathway: barrier to anti-tumor immunity","volume":"193","author":"Ostrand-Rosenberg","year":"2014","journal-title":"J\u00a0Immunol"},{"issue":"Suppl A","key":"10.1016\/j.ebiom.2023.104740_bib2","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1053\/plac.2002.0813","article-title":"B7 family molecules: novel immunomodulators at the maternal-fetal interface","volume":"23","author":"Petroff","year":"2002","journal-title":"Placenta"},{"key":"10.1016\/j.ebiom.2023.104740_bib3","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1095\/biolreprod.105.046581","article-title":"Trophoblast CD274 (B7-H1) is differentially expressed across gestation: influence of oxygen concentration","volume":"74","author":"Holets","year":"2006","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ebiom.2023.104740_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1084\/jem.20050019","article-title":"A\u00a0critical role for the programmed death ligand 1 in fetomaternal tolerance","volume":"202","author":"Guleria","year":"2005","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.ebiom.2023.104740_bib5","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.4049\/jimmunol.179.8.5211","article-title":"A\u00a0link between PDL1 and T regulatory cells in fetomaternal tolerance","volume":"179","author":"Habicht","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ebiom.2023.104740_bib6","doi-asserted-by":"crossref","first-page":"12293","DOI":"10.1073\/pnas.192461099","article-title":"Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade","volume":"99","author":"Iwai","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2023.104740_bib7","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion","volume":"8","author":"Dong","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2023.104740_bib8","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1200\/JCO.2009.26.7609","article-title":"Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates","volume":"28","author":"Brahmer","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ebiom.2023.104740_bib9","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.2337\/dbi18-0002","article-title":"Collateral damage: insulin-dependent diabetes induced with checkpoint inhibitors","volume":"67","author":"Stamatouli","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.ebiom.2023.104740_bib10","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 diabetes","volume":"391","author":"DiMeglio","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2023.104740_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1084\/jem.20111187","article-title":"Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients","volume":"209","author":"Coppieters","year":"2012","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.ebiom.2023.104740_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00125-020-05298-y","article-title":"Presumption of guilt for T cells in type 1 diabetes: lead culprits or partners in crime depending on age of onset?","volume":"64","author":"Carr\u00e9","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.ebiom.2023.104740_bib13","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1172\/JCI94549","article-title":"Autoreactive T cells in type 1 diabetes","volume":"127","author":"Pugliese","year":"2017","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ebiom.2023.104740_bib14","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2107208118","article-title":"Human islet T cells are highly reactive to preproinsulin in type 1 diabetes","volume":"118","author":"Anderson","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ebiom.2023.104740_bib15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41586-020-2631-z","article-title":"Immune-evasive human islet-like organoids ameliorate diabetes","volume":"586","author":"Yoshihara","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2023.104740_bib16","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.1038\/s41467-022-34069-z","article-title":"The type 1 diabetes gene TYK2 regulates \u03b2-cell development and its responses to interferon-\u03b1","volume":"13","author":"Chandra","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2023.104740_bib17","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.4049\/jimmunol.173.11.7017","article-title":"CXC chemokine ligand 10 neutralization suppresses the occurrence of diabetes in nonobese diabetic mice through enhanced beta cell proliferation without affecting insulitis","volume":"173","author":"Morimoto","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ebiom.2023.104740_bib18","article-title":"Engineering human stem cell-derived islets to evade immune rejection and promote localized immune tolerance","volume":"4","author":"Gerace","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ebiom.2023.104740_bib19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41571-022-00601-9","article-title":"Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics","volume":"19","author":"Yamaguchi","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ebiom.2023.104740_bib20","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression","volume":"19","author":"Garcia-Diaz","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.ebiom.2023.104740_bib21","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.3390\/cancers12113099","article-title":"Transforming growth factor-\u03b2: a multifunctional regulator of cancer immunity","volume":"12","author":"Xue","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ebiom.2023.104740_bib22","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.4049\/jimmunol.0900974","article-title":"TLR3-stimulated dendritic cells up-regulate B7-H1 expression and influence the magnitude of CD8 T cell responses to tumor vaccination","volume":"183","author":"Pulko","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ebiom.2023.104740_bib23","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.immuni.2017.11.016","article-title":"Oncogenic RAS signaling promotes tumor immunoresistance by stabilizing PD-L1 mRNA","volume":"47","author":"Coelho","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2023.104740_bib24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1158\/0008-5472.CAN-14-3362","article-title":"Control of PD-L1 expression by oncogenic activation of the AKT-mTOR pathway in non-small cell lung cancer","volume":"76","author":"Lastwika","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.ebiom.2023.104740_bib25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nm1517","article-title":"Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma","volume":"13","author":"Parsa","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2023.104740_bib26","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ccr.2014.03.033","article-title":"Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expression","volume":"25","author":"Xu","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ebiom.2023.104740_bib27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1158\/2326-6066.CIR-13-0127","article-title":"PD-L1 expression in triple-negative breast cancer","volume":"2","author":"Mittendorf","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ebiom.2023.104740_bib28","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/s41467-019-08887-7","article-title":"The Aryl hydrocarbon receptor mediates tobacco-induced PD-L1 expression and is associated with response to immunotherapy","volume":"10","author":"Wang","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2023.104740_bib29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0092-8674(82)90427-5","article-title":"The Ah locus: correlation of intranuclear appearance of inducer-receptor complex with induction of cytochrome P1-450 mRNA","volume":"31","author":"Tukey","year":"1982","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2023.104740_bib30","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.1016\/S0021-9258(17)33205-2","article-title":"Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase","volume":"251","author":"Poland","year":"1976","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ebiom.2023.104740_bib31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/toxsci\/kfq024","article-title":"Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling","volume":"115","author":"DiNatale","year":"2010","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.ebiom.2023.104740_bib32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1124\/mol.64.3.550","article-title":"Aspartate aminotransferase generates proagonists of the aryl hydrocarbon receptor","volume":"64","author":"Bittinger","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.ebiom.2023.104740_bib33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/abbi.2000.2037","article-title":"Regulation of CYP1A1 transcription via the metabolism of the tryptophan-derived 6-formylindolo[3,2-b]carbazole","volume":"383","author":"Wei","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.ebiom.2023.104740_bib34","doi-asserted-by":"crossref","first-page":"32824","DOI":"10.1074\/jbc.272.52.32824","article-title":"Expression of the human aryl hydrocarbon receptor complex in yeast. Activation of transcription by indole compounds","volume":"272","author":"Miller","year":"1997","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ebiom.2023.104740_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69758-6","article-title":"Regulated expression and function of the GABAB receptor in human pancreatic beta cell line and islets","volume":"10","author":"Rachdi","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2023.104740_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101060","article-title":"Purification of pancreatic endocrine subsets reveals increased iron metabolism in beta cells","volume":"42","author":"Berthault","year":"2020","journal-title":"Mol Metab"},{"key":"10.1016\/j.ebiom.2023.104740_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1216","article-title":"A\u00a0T-cell reporter platform for high-throughput and reliable investigation of TCR function and biology","volume":"9","author":"M\u00fcller","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.ebiom.2023.104740_bib39","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jim.2016.01.007","article-title":"Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: simultaneous measurement of NF-\u03baB, NFAT and AP-1","volume":"430","author":"Jutz","year":"2016","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.ebiom.2023.104740_bib40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/ni.2206","article-title":"Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes","volume":"13","author":"Bulek","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ebiom.2023.104740_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aao4013","article-title":"Islet-reactive CD8+ T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors","volume":"3","author":"Culina","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ebiom.2023.104740_bib42","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1191536","article-title":"Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells","volume":"329","author":"Boitano","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2023.104740_bib43","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1124\/mol.105.021832","article-title":"Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor","volume":"69","author":"Kim","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.ebiom.2023.104740_bib44","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.4049\/jimmunol.181.9.5842","article-title":"Cutting edge: IFN-gamma enables APC to promote memory Th17 and abate Th1 cell development","volume":"181","author":"Kryczek","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ebiom.2023.104740_bib45","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1677\/joe.0.1510349","article-title":"Mechanisms of amino acid-induced insulin secretion from the glucose-responsive BRIN-BD11 pancreatic B-cell line","volume":"151","author":"McClenaghan","year":"1996","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.ebiom.2023.104740_bib46","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.molcel.2020.10.015","article-title":"Inhibition of glutamine utilization synergizes with immune checkpoint inhibitor to promote antitumor immunity","volume":"80","author":"Byun","year":"2020","journal-title":"Mol Cell"},{"key":"10.1016\/j.ebiom.2023.104740_bib47","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41574-020-00443-4","article-title":"Type 1 diabetes mellitus as a disease of the \u03b2-cell (do not blame the immune system?)","volume":"17","author":"Roep","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ebiom.2023.104740_bib48","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/sj.cdd.4401073","article-title":"T\u00a0cell apoptosis by tryptophan catabolism","volume":"9","author":"Fallarino","year":"2002","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.ebiom.2023.104740_bib49","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","article-title":"Gut microbiota regulation of tryptophan metabolism in health and disease","volume":"23","author":"Agus","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ebiom.2023.104740_bib50","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","article-title":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond","volume":"18","author":"Platten","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ebiom.2023.104740_bib51","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","article-title":"Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22","volume":"39","author":"Zelante","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2023.104740_bib52","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.chembiol.2015.02.005","article-title":"Biosynthetic manipulation of tryptophan in bacteria: pathways and mechanisms","volume":"22","author":"Alkhalaf","year":"2015","journal-title":"Chem Biol"},{"key":"10.1016\/j.ebiom.2023.104740_bib53","doi-asserted-by":"crossref","first-page":"5538","DOI":"10.4049\/jimmunol.169.10.5538","article-title":"Expression of programmed death 1 ligands by murine T cells and APC","volume":"169","author":"Yamazaki","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ebiom.2023.104740_bib54","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1002\/eji.200324228","article-title":"Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses","volume":"33","author":"Liang","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ebiom.2023.104740_bib55","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-2249.2009.04087.x","article-title":"Islet inflammation and CXCL10 in recent-onset type 1 diabetes","volume":"159","author":"Roep","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ebiom.2023.104740_bib56","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/08916930410001713124","article-title":"IP-10 and type 1 diabetes: a question of time and location","volume":"37","author":"Christen","year":"2004","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ebiom.2023.104740_bib57","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1073\/pnas.0931259100","article-title":"PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells","volume":"100","author":"Loke","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2023.104740_bib58","doi-asserted-by":"crossref","first-page":"31924","DOI":"10.1074\/jbc.M507057200","article-title":"Identification of N10-substituted phenoxazines as potent and specific inhibitors of Akt signaling","volume":"280","author":"Thimmaiah","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ebiom.2023.104740_bib59","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nchembio.208","article-title":"Structure and allosteric effects of low-molecular-weight activators on the protein kinase PDK1","volume":"5","author":"Hindie","year":"2009","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.ebiom.2023.104740_bib60","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0960-9822(06)00122-9","article-title":"Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha","volume":"7","author":"Alessi","year":"1997","journal-title":"Curr Biol"},{"key":"10.1016\/j.ebiom.2023.104740_bib61","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1677\/joe.0.1500077","article-title":"Superior potency of infused IGF-I analogues which bind poorly to IGF-binding proteins is maintained when administered by injection","volume":"150","author":"Tomas","year":"1996","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.ebiom.2023.104740_bib62","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.celrep.2018.03.109","article-title":"Gut microbiota-derived tryptophan metabolites modulate inflammatory response in hepatocytes and macrophages","volume":"23","author":"Krishnan","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.ebiom.2023.104740_bib63","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nm.4102","article-title":"CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands","volume":"22","author":"Lamas","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2023.104740_bib64","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1016\/j.bmcl.2012.07.063","article-title":"Discovery and optimization of a novel series of GPR142 agonists for the treatment of type 2 diabetes mellitus","volume":"22","author":"Lizarzaburu","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ebiom.2023.104740_bib65","article-title":"GPR142 controls tryptophan-induced insulin and incretin hormone secretion to improve glucose metabolism","volume":"11","author":"Lin","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2023.104740_bib66","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0303-7207(86)90034-1","article-title":"Aromatic amino acids and pancreatic islet function: a comparison of L-tryptophan and L-5-hydroxytryptophan","volume":"48","author":"Lindstr\u00f6m","year":"1986","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ebiom.2023.104740_bib67","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.molmet.2018.02.008","article-title":"GPR142 prompts glucagon-like peptide-1 release from islets to improve \u03b2 cell function","volume":"11","author":"Lin","year":"2018","journal-title":"Mol Metabol"},{"key":"10.1016\/j.ebiom.2023.104740_bib68","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1124\/mol.115.100412","article-title":"GPR139, an orphan receptor highly enriched in the habenula and septum, is activated by the essential amino acids L-tryptophan and L-phenylalanine","volume":"88","author":"Liu","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.ebiom.2023.104740_bib69","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/sj.bjp.0706948","article-title":"Trace amine-associated receptors and their ligands","volume":"149","author":"Zucchi","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ebiom.2023.104740_bib70","doi-asserted-by":"crossref","first-page":"22021","DOI":"10.1074\/jbc.M603503200","article-title":"Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35","volume":"281","author":"Wang","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ebiom.2023.104740_bib71","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.tips.2020.11.006","article-title":"Tryptophan metabolism as a pharmacological target","volume":"42","author":"Modoux","year":"2021","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.ebiom.2023.104740_bib72","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.it.2012.10.001","article-title":"Indoleamine 2,3 dioxygenase and metabolic control of immune responses","volume":"34","author":"Munn","year":"2013","journal-title":"Trends Immunol"},{"key":"10.1016\/j.ebiom.2023.104740_bib73","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1073\/pnas.83.17.6622","article-title":"Interferon enhances tryptophan metabolism by inducing pulmonary indoleamine 2,3-dioxygenase: its possible occurrence in cancer patients","volume":"83","author":"Yasui","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2023.104740_bib74","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.2337\/db17-1281","article-title":"Loss of IDO1 expression from human pancreatic \u03b2-cells precedes their destruction during the development of type 1 diabetes","volume":"67","author":"Anquetil","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.ebiom.2023.104740_bib75","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nm.2173","article-title":"Serotonin regulates pancreatic beta cell mass during pregnancy","volume":"16","author":"Kim","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2023.104740_bib76","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.2337\/db10-1192","article-title":"Convergence of the insulin and serotonin programs in the pancreatic \u03b2-cell","volume":"60","author":"Ohta","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.ebiom.2023.104740_bib77","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1124\/pr.113.007823","article-title":"Aryl hydrocarbon receptor control of adaptive immunity","volume":"65","author":"Quintana","year":"2013","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ebiom.2023.104740_bib78","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF00745138","article-title":"Accumulation of dopamine in mouse pancreatic B-cells following injection of L-DOPA. Localization to secretory granules and inhibition of insulin secretion","volume":"13","author":"Ericson","year":"1977","journal-title":"Diabetologia"},{"key":"10.1016\/j.ebiom.2023.104740_bib79","doi-asserted-by":"crossref","first-page":"12674","DOI":"10.1073\/pnas.1203795109","article-title":"Anti\u2013IL-7 receptor-\u03b1 reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function","volume":"109","author":"Lee","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2023.104740_bib80","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.molmet.2015.09.015","article-title":"Incretin-like effects of small molecule trace amine-associated receptor 1 agonists","volume":"5","author":"Raab","year":"2016","journal-title":"Mol Metab"},{"key":"10.1016\/j.ebiom.2023.104740_bib81","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1038\/s41388-018-0303-3","article-title":"Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations","volume":"37","author":"Zerdes","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.ebiom.2023.104740_bib82","doi-asserted-by":"crossref","first-page":"9250","DOI":"10.1073\/pnas.0803047105","article-title":"Disruption of Tsc2 in pancreatic beta cells induces beta cell mass expansion and improved glucose tolerance in a TORC1-dependent manner","volume":"105","author":"Rachdi","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2023.104740_bib83","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1172\/JCI200113785","article-title":"Islet beta cell expression of constitutively active Akt1\/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia","volume":"108","author":"Bernal-Mizrachi","year":"2001","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ebiom.2023.104740_bib84","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ebiom.2018.09.040","article-title":"PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-\u03b1 and-\u03b3 via IRF1 induction","volume":"36","author":"Colli","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2023.104740_bib85","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1007\/s00125-016-4067-4","article-title":"Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes","volume":"59","author":"Richardson","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.ebiom.2023.104740_bib86","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1172\/JCI129484","article-title":"The supply chain of human pancreatic \u03b2 cell lines","volume":"129","author":"Scharfmann","year":"2019","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ebiom.2023.104740_bib87","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41577-019-0200-1","article-title":"Engineering universal cells that evade immune detection","volume":"19","author":"Lanza","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2023.104740_bib88","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.4049\/jimmunol.1900475","article-title":"Frequent loss of IRF2 in cancers leads to immune evasion through decreased MHC class I antigen presentation and increased PD-L1 expression","volume":"203","author":"Kriegsman","year":"2019","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ebiom.2023.104740_bib89","first-page":"773","article-title":"A\u00a0randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis","volume":"261","author":"Vollmer","year":"2014","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ebiom.2023.104740_bib90","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/gutjnl-2014-307118","article-title":"A\u00a0phase II study of laquinimod in Crohn\u2019s disease","volume":"64","author":"D\u2019Haens","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.ebiom.2023.104740_bib91","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.phrs.2014.10.009","article-title":"Tranilast: a review of its therapeutic applications","volume":"91","author":"Darakhshan","year":"2015","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ebiom.2023.104740_bib92","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jaad.2018.10.037","article-title":"Phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of plaque psoriasis","volume":"80","author":"Robbins","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423003055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423003055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T19:48:59Z","timestamp":1779306539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396423003055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":91,"alternative-id":["S2352396423003055"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104740","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tryptophan metabolism promotes immune evasion in human pancreatic \u03b2 cells","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104740","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104740"}}